Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
41,966,083
-
Total 13F shares
-
8,506,493
-
Share change
-
-493,282
-
Total reported value
-
$19,308,656
-
Price per share
-
$2.27
-
Number of holders
-
49
-
Value change
-
-$1,165,944
-
Number of buys
-
18
-
Number of sells
-
25
Institutional Holders of Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM) as of Q1 2024
As of 31 Mar 2024,
Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,506,493 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, TPG GP A, LLC, TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and Nuveen Asset Management, LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.